Optimizing escalation: Ceftolozane/tazobactam versus treatment with traditional anti-pseudomonal β-lactams for pneumonia or bloodstream infections due to MDR P. aeruginosa (STEWARDS) Grant uri icon

Overview

date/time interval

  • April 30, 2025 - December 12, 2027

sponsor award ID

  • UP 243556-01

Affiliation